VISITORS SINCE MAY 2004

To receive regular news and updates, enter e-mail address below:

Feedback

Suggestions, questions or comments are always appreciated. Send them to feedback@centigray.com

Disclaimer

The information presented here is for my own personal use. It is not meant to be an authoritative reference on the diagnosis or management of any disease or condition. Any use of copyrighted material is unintentional and will be removed immediately at the author's request. Use of this site is not a substitute for consultation with a qualified health professional. Physicians using this site should remember to be skeptical of the written word, question everything and trust no one.

March

Leidenius MH, Krogerus LA, Toivonen TS, Leppanen EA, von Smitten KA.
The clinical value of parasternal sentinel node biopsy in breast cancer. Ann Surg Oncol. 2006 Mar;13(3):321-6.

Wong SL, Brady MS, Busam KJ, Coit DG.
Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol. 2006 Mar;13(3):302-9.

Tulchinsky H, Rabau M, Shacham-Shemueli E, Goldman G, Geva R, Inbar M, Klausner JM, Figer A.
Can Rectal Cancers With Pathologic T0 After Neoadjuvant Chemoradiation (ypT0) Be Treated by Transanal Excision Alone? Ann Surg Oncol. 2006 Mar;13(3):347-52.

Aziz O, Constantinides V, Tekkis PP, Athanasiou T, Purkayastha S, Paraskeva P, Darzi AW, Heriot AG.
Laparoscopic Versus Open Surgery for Rectal Cancer: A Meta-Analysis. Ann Surg Oncol. 2006 Mar;13(3):413-424.

Bernstein ED, Herbert SM, Hanna NH.
Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer. Ann Surg Oncol. 2006 Mar;13(3):291-301.

Rodgers JK, Sawhney R, Chaudhary U, Bissada NK.
Quality of life in men with localized prostate cancer treated by radical prostatectomy or radiotherapy. Arch Androl. 2006 Mar-Apr;52(2):129-33.

Murthy V, Norman AR, Shahidi M, Parker CC, Horwich A, Huddart RA, Bange A, Dearnaley DP.
Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer. BJU Int. 2006 Mar;97(3):476-9.

Apter S, Shemesh J, Raanani P, Portnoy O, Thaler M, Zissin R, Ezra D, Rozenman J, Pfeffer R, Hertz M.
Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation. Coron Artery Dis. 2006 Mar;17(2):145-51.

Gauvrit JY, Oppenheim C, Nataf F, Naggara O, Trystram D, Munier T, Fredy D, Pruvo JP, Roux FX, Leclerc X, Meder JF.
Three-dimensional dynamic magnetic resonance angiography for the evaluation of radiosurgically treated cerebral arteriovenous malformations. Eur Radiol. 2006 Mar;16(3):583-91.

Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA.
Intensity-modulated radiotherapy in high-grade gliomas: Clinical and dosimetric results. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):892-7.

Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD.
Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):898-903.

Nicolato A, Lupidi F, Sandri MF, Foroni R, Zampieri P, Mazza C, Pasqualin A, Beltramello A, Gerosa M.
Gamma Knife radiosurgery for cerebral arteriovenous malformations in children/adolescents and adults. Part II: Differences in obliteration rates, treatment-obliteration intervals, and prognostic factors. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):914-21.

Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ.
Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of bladder volume. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):835-41.

Cury FL, Souhami L, Rajan R, Tanguay S, Gagnon B, Duclos M, Shenouda G, Faria SL, David M, Freeman CR.
Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):842-8.

Nicolato A, Lupidi F, Sandri MF, Foroni R, Zampieri P, Mazza C, Maluta S, Beltramello A, Gerosa M.
Gamma Knife radiosurgery for cerebral arteriovenous malformations in children/adolescents and adults. Part I: Differences in epidemiologic, morphologic, and clinical characteristics, permanent complications, and bleeding in the latency period. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):904-13.

Lind PA, Wennberg B, Gagliardi G, Rosfors S, Blom-Goldman U, Lidestahl A, Svane G.
ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):765-70.

Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS, Wong R, Siu LL, Moore M, Brierley J.
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):709-16.

Mazonakis M, Damilakis J, Varveris H, Gourtsouiannis N.
Radiation dose to testes and risk of infertility from radiotherapy for rectal cancer. Oncol Rep. 2006 Mar;15(3):729-33.

February

Schaapveld M, de Vries EG, van der Graaf WT, Otter R, de Vries J, Willemse PH.
The Prognostic Effect of the Number of Histologically Examined Axillary Lymph Nodes in Breast Cancer: Stage Migration or Age Association? Ann Surg Oncol. 2006 Feb 20;

Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, Verma S, Dent S, Sawka C, Pritchard KI, Ginsburg D, Wood M, Whelan T.
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006 Feb 20;24(6):848-55.

Redston M, Compton CC, Miedema BW, Niedzwiecki D, Dowell JM, Jewell SD, Fleshman JM, Bem J, Mayer RJ, Bertagnolli MM.
Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of cancer and leukemia group B trial 80001. J Clin Oncol. 2006 Feb 20;24(6):878-83.

Westphal M, Ram Z, Riddle V, Hilt D, Bortey E; On behalf of the Executive Committee of the Gliadel(R) Study Group.
Gliadel((R)) wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien). 2006 Feb 17;

van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, Kroon BB.
Sentinel Node Biopsy Before Neoadjuvant Chemotherapy Spares Breast Cancer Patients Axillary Lymph Node Dissection. Ann Surg Oncol. 2006 Feb 17;

Goldenberg D, Sciubba J, Koch WM.
Cystic metastasis from head and neck squamous cell cancer: A distinct disease variant? Head Neck. 2006 Feb 13;

McMillan AS, Pow EH, Kwong DL, Wong MC, Sham JS, Leung LH, Leung WK.
Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: Results of a prospective longitudinal study. Head Neck. 2006 Feb 10;

Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E, Harris AL.
Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol. 2006 Feb 10;24(5):727-35.

Bajetta E, Del Vecchio M, Nova P, Fusi A, Daponte A, Sertoli MR, Queirolo P, Taveggia P, Bernengo MG, Legha SS, Formisano B, Cascinelli N.
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-{alpha}2b in metastatic melanoma. Ann Oncol. 2006 Feb 9;

Stafinski T, Jhangri GS, Yan E, Menon D.
Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: A systematic review and meta-analysis. Cancer Treat Rev. 2006 Feb 9;

Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK.
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006 Feb 9;354(6):567-78.

Kreth FW, Faist M, Grau S, Ostertag CB.
Interstitial (125)I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors. Cancer. 2006 Feb 8;

Ortholan C, Francois E, Thomas O, Benchimol D, Baulieux J, Bosset JF, Gerard JP.
Role of Radiotherapy With Surgery for T3 and Resectable T4 Rectal Cancer: Evidence From Randomized Trials. Dis Colon Rectum. 2006 Feb 6;

Mangar S, Slevin N, Mais K, Sykes A.
Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: A retrospective review. Radiother Oncol. 2006 Feb 5;

Perry A, Schmidt RE.
Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol (Berl). 2006 Feb 4;:1-16

Combs SE, Thilmann C, Debus J, Schulz-Ertner D.
Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Int J Radiat Oncol Biol Phys. 2006 Feb 4;

Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L, Nicolaou N.
Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol. 2006 Feb;29(1):66-70.

Brown P, Clark MM, Atherton P, Huschka M, Sloan JA, Gamble G, Girardi J, Frost MH, Piderman K, Rummans TA.
Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer? Am J Clin Oncol. 2006 Feb;29(1):52-8.

Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Werning JW, Villaret DB.
Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol. 2006 Feb;29(1):32-9.

Bastasch MD, Teh BS, Mai WY, McGary JE, Grant WH 3rd, Butler EB.
Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer. Am J Clin Oncol. 2006 Feb;29(1):8-11.

Vaquerano J, Kraybill WG, Driscoll DL, Cheney R, Kane JM 3rd.
American joint committee on cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma. Ann Surg Oncol. 2006 Feb;13(2):198-204.

Regel JP, Schoch B, Sandalcioglu IE, Wieland R, Westermeier C, Stolke D, Wiedemayer H.
Malignant meningioma as a second malignancy after therapy for acute lymphatic leukemia without cranial radiation. Childs Nerv Syst. 2006 Feb;22(2):172-5.

Incrocci L.
Sexual function after external-beam radiotherapy for prostate cancer: What do we know? Crit Rev Oncol Hematol. 2006 Feb;57(2):165-73.

Tateya I, Hirano S, Kojima H, Omori K, Shoji K, Mitsumori M, Nagata Y, Ito J.
Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx. Eur Arch Otorhinolaryngol. 2006 Feb;263(2):144-8.

Truong PT, Woodward WA, Buchholz TA.
Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy. Expert Rev Anticancer Ther. 2006 Feb;6(2):205-16.

Ansarin M, Zabrodsky M, Bianchi L, Renne G, Tosoni A, Calabrese L, Tredici P, Jereczek-Fossa BA, Orecchia R, Chiesa F.
Endoscopic CO2 laser surgery for early glottic cancer in patients who are candidates for radiotherapy: results of a prospective nonrandomized study. Head Neck. 2006 Feb;28(2):121-5.

Tham IW, Lee KM, Yap SP, Loong SL.
Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy. Head Neck. 2006 Feb;28(2):126-34.

Pellitteri PK, Ferlito A, Rinaldo A, Shah JP, Weber RS, Lowry J, Medina JE, Gourin CG, Robbins KT, Suarez C, Shaha AR, Genden EM, Leemans CR, Lefebvre JL, Kowalski LP, Wei WI.
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck. 2006 Feb;28(2):166-75.

Massager N, Nissim O, Delbrouck C, Devriendt D, David P, Desmedt F, Wikler D, Hassid S, Brotchi J, Levivier M.
Role of intracanalicular volumetric and dosimetric parameters on hearing preservation after vestibular schwannoma radiosurgery. Int J Radiat Oncol Biol Phys. 2006 Feb 1;

van Tol-Geerdink JJ, Stalmeier PF, Pasker-de Jong PC, Huizenga H, van Lin EN, Schimmel EC, Leer JW, van Daal WA.
Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):534-43.

Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB.
12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):419-24.

Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S.
Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):449-54.

Czito BG, Willett CG, Bendell JC, Morse MA, Tyler DS, Fernando NH, Mantyh CR, Blobe GC, Honeycutt W, Yu D, Clary BM, Pappas TN, Ludwig KA, Hurwitz HI.
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol. 2006 Feb 1;24(4):656-62.

Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, Johnson ME, Gamble G, Richardson J, Brown P, Martensen J, Miller J, Piderman K, Huschka M, Girardi J, Hanson J.
Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006 Feb 1;24(4):635-42.

Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR.
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. J Clin Oncol. 2006 Feb 1;24(4):605-11.

Barakat RR, Bundy BN, Spirtos NM, Bell J, Mannel RS; Gynecologic Oncology Group Study.
Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2006 Feb 1;24(4):587-92.

Kim JS, Kim JS, Cho MJ, Yoon WH, Song KS.
Comparison of the Efficacy of Oral Capecitabine versus Bolus 5-FU in Preoperative Radiotherapy of Locally Advanced Rectal Cancer. J Korean Med Sci. 2006 Feb;21(1):52-7.

Christopoulou A, Retsas S, Kingsley D, Paddick I, Lindquist C.
Integration of gamma knife surgery in the management of cerebral metastases from melanoma. Melanoma Res. 2006 Feb;16(1):51-7.

Wanebo JE, Bristol RE, Porter RR, Coons SW, Spetzler RF.
Management of cranial base chondrosarcomas. Neurosurgery. 2006 Feb;58(2):249-55; discussion 249-55.

Pollock BE.
Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery. 2006 Feb;58(2):241-8; discussion 241-8.

Lee DJ, Maseyesva B, Westra W, Long D, Niparko JK, Califano J.
Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery. Otol Neurotol. 2006 Feb;27(2):213-9.

Ascherman JA, Hanasono MM, Newman MI, Hughes DB.
Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg. 2006 Feb;117(2):359-65.

Erbay SH, Bhadelia RA, O'Callaghan M, Gupta P, Riesenburger R, Krackov W, Polak JF.
Nerve atrophy in severe trigeminal neuralgia: noninvasive confirmation at MR imaging--initial experience. Radiology. 2006 Feb;238(2):689-92.

Roberge D, Souhami L, Olivier A, Leblanc R, Podgorsak E.
Hypofractionated Stereotactic Radiotherapy for Low Grade Glioma at McGill University: Long-term Follow-up. Technol Cancer Res Treat. 2006 Feb;5(1):1-8.

Rossi PJ, Clark PE, Papagikos MA, McCullough DL, Lee WR.
Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. Urology. 2006 Feb;67(2):349-53.

January

Woo TC, Pignol JP, Rakovitch E, Vu T, Hicks D, O'brien P, Pritchard K.
Body radiation exposure in breast cancer radiotherapy: impact of breast IMRT and virtual wedge compensation techniques. Int J Radiat Oncol Biol Phys. 2006 Jan 31;

Pergolizzi S, Adamo V, Russi E, Santacaterina A, Maisano R, Numico G, Palazzolo C, Ferrau F, Settineri N, Altavilla G, Girlando A, Spadaro P, Cascinu S.
Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases. Int J Radiat Oncol Biol Phys. 2006 Jan 27;

Fuentes R, Bonfill X, Exposito J.
Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004840.

Al-Shahi R, Warlow C.
Interventions for treating brain arteriovenous malformations in adults. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003436.

Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK.
Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA. 2006 Jan 25;295(4):389-97

Lemanski C, Azria D, Thezenas S, Gutowski M, Saint-Aubert B, Rouanet P, Fenoglietto P, Ailleres N, Dubois JB.
Intraoperative radiotherapy given as a boost for early breast cancer: Long-term clinical and cosmetic results. Int J Radiat Oncol Biol Phys. 2006 Jan 24;

Underberg RW, Lagerwaard FJ, van Tinteren H, Cuijpers JP, Slotman BJ, Senan S.
Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Jan 24;

Mac Manus MP, Matthews JP, Wada M, Wirth A, Worotniuk V, Ball DL.
Unexpected long-term survival after low-dose palliative radiotherapy for nonsmall cell lung cancer. Cancer. 2006 Jan 23;

Aryan HE, Nakaji P, Lu DC, Alksne JF.
Multimodality treatment of trigeminal neuralgia: impact of radiosurgery and high resolution magnetic resonance imaging. J Clin Neurosci. 2006 Jan 23;

Zhang M, Moiseenko V, Liu M, Craig T.
Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations. Phys Med Biol. 2006 Jan 21;51(2):269-85.

Burkhardt B, Woessmann W, Zimmermann M, Kontny U, Vormoor J, Doerffel W, Mann G, Henze G, Niggli F, Ludwig WD, Janssen D, Riehm H, Schrappe M, Reiter A.
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol. 2006 Jan 20;24(3):491-9.

Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC.
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006 Jan 20;24(3):361-9.

Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Pinol V, Bessa X, Batiste-Alentorn E, Lacy AM, Delgado S, Maurel J, Pique JM, Castells A.
Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006 Jan 20;24(3):386-93.

Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS; International Breast Cancer Study Group.
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006 Jan 20;24(3):337-44.

Mori Y, Kobayashi T, Kida Y, Oda K, Shibamoto Y, Yoshida J.
Stereotactic Radiosurgery as a Salvage Treatment for Recurrent Skull Base Adenoid Cystic Carcinoma. Stereotact Funct Neurosurg. 2006 Jan 19;83(5-6):202-207

Shipley WU, Desilvio M, Pilepich MV, Roach M 3rd, Wolkov HB, Sause WT, Rubin P, Lawton CA.
Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10. Int J Radiat Oncol Biol Phys. 2006 Jan 18;

Rodrigo JP, Cabanillas R, Franco V, Suarez C.
Efficacy of routine bilateral neck dissection in the management of the N0 neck in T1-T2 unilateral supraglottic cancer. Head Neck. 2006 Jan 17;

Vaidya JS, Walton L, Dewar J.
Single dose targeted intraoperative radiotherapy (TARGIT) for breast cancer can be delivered as a second procedure under local anaesthetic. World J Surg Oncol. 2006 Jan 17;4:2.

Peeters ST, Lebesque JV, Heemsbergen WD, van Putten WL, Slot A, Dielwart MF, Koper PC.
Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Jan 13;

Ishiyama H, Kitano M, Satoh T, Niibe Y, Uemae M, Fujita T, Baba S, Hayakawa K.
Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer. Radiother Oncol. 2006 Jan 13;

Nielsen M, Hansen O, Vach W.
Attempts to predict the long-term decrease in lung function due to radiotherapy of non-small cell lung cancer. Radiother Oncol. 2006 Jan 12;

Yartsev S, Chen J, Yu E, Kron T, Rodrigues G, Coad T, Trenka K, Wong E, Bauman G, Dyk JV.
Comparative planning evaluation of intensity-modulatedradiotherapy techniques for complex lung cancer cases. Radiother Oncol. 2006 Jan 12;

Rades D, Schild SE.
Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Cancer. 2006 Jan 6;

Pickles T; British Columbia Cancer Agency Prostate Cohort Outcomes Initiative.
Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy. Int J Radiat Oncol Biol Phys. 2006 Jan 5;

Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N, Nakano T.
Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys. 2006 Jan 4;

Akimoto T, Katoh H, Kitamoto Y, Shirai K, Shioya M, Nakano T.
Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: Comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization. Int J Radiat Oncol Biol Phys. 2006 Jan 4;

Gebski V, Lagleva M, Keech A, Simes J, Langlands AO.
Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst. 2006 Jan 4;98(1):26-38.

Reyns N, Hayashi M, Chinot O, Manera L, Peragut JC, Blond S, Regis J.
The role of Gamma Knife radiosurgery in the treatment of pineal parenchymal tumours. Acta Neurochir (Wien). 2006 Jan;148(1):5-11.

Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle JO, Wong RJ, Shaha AR, Lee N, Shah JP.
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):59-66.

Korkolis DP, Plataniotis GD, Gondikakis E, Xinopoulos D, Koulaxouzidis GV, Katsilieris J, Vassilopoulos PP.
Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer. Int J Colorectal Dis. 2006 Jan;21(1):1-6.

Song WY, Schaly B, Bauman G, Battista JJ, Van Dyk J.
Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: A radiobiologic analysis. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):289-300.

Chen M, Hayman JA, Ten Haken RK, Tatro D, Fernando S, Kong FM.
Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):120-6.

Sanguineti G, Cavey ML, Endres EJ, Brandon GG, Bayouth JE.
Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer? Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):151-60.

Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, Hwu P, Zagars GK.
Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):106-13.

Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M.
Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):77-82.

Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, Yu ZH.
Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol. 2006 Jan 1;24(1):181-9.

Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA; Gynecologic Oncology Group Study.
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2006 Jan 1;24(1):36-44.

Suh JH, Stea B, Nabid A, Kresl JJ, Fortin A, Mercier JP, Senzer N, Chang EL, Boyd AP, Cagnoni PJ, Shaw E.
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 2006 Jan 1;24(1):106-14.

Deinsberger R, Tidstrand J.
LINAC Radiosurgery as Single Treatment in Cerebral Metastases. J Neurooncol. 2006 Jan;76(1):77-83.

Kidd EA, Mansur DB, Leonard JR, Michalski JM, Simpson JR, Perry A.
The efficacy of radiation therapy in the management of grade I astrocytomas. J Neurooncol. 2006 Jan;76(1):55-8.

Hofmann M, Kiecker F, Wurm R, Schlenger L, Budach V, Sterry W, Trefzer U.
Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol. 2006 Jan;76(1):59-64.

Douglas JG, Rockhill JK, Olson JM, Ellenbogen RG, Geyer JR.
Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas. J Pediatr Hematol Oncol. 2006 Jan;28(1):36-9.

D'cruz AK, Pantvaidya GH, Agarwal JP, Chaukar DA, Pathak KA, Deshpande MS, Pai PS, Chaturvedi P, Dinshaw KA.
Split therapy: planned neck dissection followed by definitive radiotherapy for a T1, T2 pharyngolaryngeal primary cancer with operable N2, N3 nodal metastases--a prospective study. J Surg Oncol. 2006 Jan 1;93(1):56-61.

Erbay SH, Bhadelia RA, Riesenburger R, Gupta P, O'callaghan M, Yun E, Oljeski S.
Association between neurovascular contact on MRI and response to gamma knife radiosurgery in trigeminal neuralgia. Neuroradiology. 2006 Jan;48(1):26-30.

Fuentes S, Delsanti C, Metellus P, Peragut JC, Grisoli F, Regis J.
Brainstem metastases: management using gamma knife radiosurgery. Neurosurgery. 2006 Jan;58(1):37-42; discussion 37-42.

Zachenhofer I, Wolfsberger S, Aichholzer M, Bertalanffy A, Roessler K, Kitz K, Knosp E.
Gamma-knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years. Neurosurgery. 2006 Jan;58(1):28-36; discussion 28-36.

Sirin S, Kondziolka D, Niranjan A, Flickinger JC, Maitz AH, Lunsford LD.
Prospective staged volume radiosurgery for large arteriovenous malformations: indications and outcomes in otherwise untreatable patients. Neurosurgery. 2006 Jan;58(1):17-27; discussion 17-27.

Goldner G, Zimmermann F, Feldmann H, Glocker S, Wachter-Gerstner N, Geinitz H, Becker G, Potzi R, Wambersie A, Bamberg M, Molls M, Wachter S, Potter R.
3-D conformal radiotherapy of localized prostate cancer: A subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects. Radiother Oncol. 2006 Jan;78(1):36-40.

Nickers P, Thissen B, Jansen N, Deneufbourg JM.
(192)Ir or (125)I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: A dosimetric point of view. Radiother Oncol. 2006 Jan;78(1):47-52.

Baum C, Alber M, Birkner M, Nusslin F.
Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities. Radiother Oncol. 2006 Jan;78(1):27-35. PMID: 16216359

Brell M, Villa S, Teixidor P, Lucas A, Ferran E, Marin S, Acebes JJ.
Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance. Surg Neurol. 2006 Jan;65(1):28-33; discussion 33-4.

Jani AB, Su A, Milano MT.
Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity. Urology. 2006 Jan;67(1):147-51.

Faria SL, Mahmud S, Souhami L, David M, Duclos M, Shenouda G, Makis W, Freeman CR.
No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy. Urology. 2006 Jan;67(1):142-6.

December

Zabel A, Milker-Zabel S, Huber P, Schlegel W, Debus J.
Linac-based Radiosurgery or Hypofractionated Stereotactic Radiotherapy in the Treatment of Large Cerebral Arteriovenous Malformations. Int J Radiat Oncol Biol Phys. 2005 Dec 21;

Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M; Intergruppo Italiano Linfomi.
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. J Clin Oncol. 2005 Dec 20;23(36):9198-207.

Tsujino K, Hirota S, Kotani Y, Kado T, Yoden E, Fujii O, Soejima T, Adachi S, Takada Y.
Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys. 2005 Dec 19;

Zabel-du Bois A, Milker-Zabel S, Huber P, Schlegel W, Debus J.
Stereotactic linac-based radiosurgery in the treatment of cerebral arteriovenous malformations located deep, involving corpus callosum, motor cortex, or brainstem. Int J Radiat Oncol Biol Phys. 2005 Dec 19;

Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD.
Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer. 2005 Dec 15;104(12):2784-91.

Lee N, Puri DR, Blanco AI, Chao KS.
Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck. 2005 Dec 15;

De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P.
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol. 2005 Dec 12;

Lee CT, Dong L, Ahamad AW, Choi H, Cheung R, Lee AK, Horne DF Jr, Breaux AJ, Kuban DA.
Comparison of treatment volumes and techniques in prostate cancer radiation therapy. Am J Clin Oncol. 2005 Dec;28(6):618-25.

Chang DT, Zlotecki RA, Olivier KR.
Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio. Am J Clin Oncol. 2005 Dec;28(6):597-602. Review.

Song DY, Benedict SH, Cardinale RM, Chung TD, Chang MG, Schmidt-Ullrich RK.
Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol. 2005 Dec;28(6):591-6.

Kelsey CR, Schefter T, Nash SR, Russ P, Baron AE, Zeng C, Gaspar LE.
Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. Am J Clin Oncol. 2005 Dec;28(6):576-80.

Dagan R, Morris CG, Zlotecki RA, Scarborough MT, Mendenhall WM.
Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol. 2005 Dec;28(6):537-9.

Combs SE, Thilmann C, Debus J, Schulz-Ertner D.
Precision radiotherapy for hemangiopericytomas of the central nervous system. Cancer. 2005 Dec 1;104(11):2457-65.

Tada T, Fukuda H, Nakagawa K, Matsui K, Hosono M, Takada Y, Inoue Y.
Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection. Int J Clin Oncol. 2005 Dec;10(6):425-8.

Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P.
Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1316-24.

Campbell B, Wirth A, Milner A, Di Iulio J, MacManus M, Ryan G.
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1538-45.

Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Biti G.
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1387-94.

Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E, De Stefani A, Buglione M, Biti G.
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1378-86

Noel G, Bollet MA, Noel S, Feuvret L, Boisserie G, Tep B, Delattre JY, Baillet F, Ambroise Valery C, Cornu P, Mazeron JJ.
Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1555-61.

Birgisson H, Pahlman L, Gunnarsson U, Glimelius B; Swedish Rectal Cancer Trial Group.
Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol. 2005 Dec 1;23(34):8697-705.

Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005 Dec 1;23(34):8580-7.

Delanian S, Porcher R, Rudant J, Lefaix JL.
Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol. 2005 Dec 1;23(34):8570-9. .

Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C.
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005 Dec 1;23(34):8688-96. .

Kobayashi T, Kida Y, Mori Y, Hasegawa T.
Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg. 2005 Dec;103(6 Suppl):482-8.

Kubo O, Chernov M, Izawa M, Hayashi M, Muragaki Y, Maruyama T, Hori T, Takakura K.
Malignant Progression of Benign Brain Tumors after Gamma Knife Radiosurgery: Is it Really Caused by Irradiation? Minim Invasive Neurosurg. 2005 Dec;48(6):334-9.

Wood K, Jawahar A, Smelley C, Mullapudi S, DeLaune A, Nanda A, Granger DN.
Exposure of brain to high-dose, focused gamma rays irradiation produces increase in leukocytes-adhesion and pavementing in small intracerebral blood vessels. Neurosurgery. 2005 Dec;57(6):1282-8; discussion 1282-8.

Richards GM, Bradley KA, Tome WA, Bentzen SM, Resnick DK, Mehta MP.
Linear accelerator radiosurgery for trigeminal neuralgia. Neurosurgery. 2005 Dec;57(6):1193-200; discussion 1193-200.

Heppner PA, Sheehan JP, Steiner LE.
Gamma knife surgery for low-grade gliomas. Neurosurgery. 2005 Dec;57(6):1132-9; discussion.

Nguyen TD, Poortmans PM, van der Hulst M, Studer G, Pigois E, Collen TD, Belkacemi Y, Beckendorf V, Miralbell R, Scandolaro L, Soete G, Villa S, Gez E, Thomas O, Krengli M, Jovenin N.
The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study. Radiother Oncol. 2005 Dec;77(3):286-9.

Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R.
Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol. 2005 Dec;77(3):247-53.

Chua DT, Sham JS, Leung LH, Au GK.
Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol. 2005 Dec;77(3):290-4. Epub 2005 Nov 8.

Christian JA, Partridge M, Nioutsikou E, Cook G, McNair HA, Cronin B, Courbon F, Bedford JL, Brada M.
The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. Radiother Oncol. 2005 Dec;77(3):271-7. Epub 2005 Nov 7.

Sajja R, Barnett GH, Lee SY, Harnisch G, Stevens GH, Lee J, Suh JH.
Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results. Technol Cancer Res Treat. 2005 Dec;4(6):675-82.

Beekman M, Merrick GS, Butler WM, Wallner KE, Allen ZA, Galbreath RW.
Selecting patients with pretreatment postvoid residual urine volume less than 100 mL may favorably influence brachytherapy-related urinary morbidity. Urology. 2005 Dec;66(6):1266-70.

Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker PD, Klein E, Cangiano T, Schroder FH, Scardino PT, Kattan MW.
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology. 2005 Dec;66(6):1245-50.

Simon M, Bostrom J, Koch P, Schramm J.
Inter-institutional variance of postoperative radiotherapy and follow up for meningiomas in Germany. Impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry. 2005 Nov 23;

Baxter NN, Habermann EB, Tepper JE, Durham SB, Virnig BA.
Risk of pelvic fractures in older women following pelvic irradiation. JAMA. 2005 Nov 23;294(20):2587-93.

Ma L, Kwok Y, Chin LS, Yu C, Regine WF.
Comparative analyses of linac and Gamma Knife radiosurgery for trigeminal neuralgia treatments. Phys Med Biol. 2005 Nov 21;50(22):5217-27. Epub 2005 Oct 24.

El Sharouni SY, Kal HB, Battermann JJ.
Tumour control probability of stage III inoperable non-small cell lung tumours after sequential chemo-radiotherapy. Anticancer Res. 2005 Nov-Dec;25(6C):4655-61.

Kim K, Kim S, Chie EK, Kim SW, Bang YJ, Ha SW.
Postoperative chemoradiotherapy of pancreatic cancer: what is the appropriate target volume of radiation therapy? Tumori. 2005 Nov-Dec;91(6):493-7.

Teloken C, DA Ros CT, Caraver F, Weber FA, Cavalheiro AP, Graziottin TM.
Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. J Urol. 2005 Dec;174(6):2178-80.

November

Ma L, Kwok Y, Chin LS, Yu C, Regine WF.
Comparative analyses of linac and Gamma Knife radiosurgery for trigeminal neuralgia treatments. Phys Med Biol. 2005 Nov 21;50(22):5217-27.

Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD.
Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer. 2005 Nov 15;

Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D.
Stereotactic radiosurgery (for glioma). Cancer. 2005 Nov 15;104(10):2168-73.

Gerszten PC, Burton SA, Welch WC, Brufsky AM, Lembersky BC, Ozhasoglu C, Vogel WJ.
Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer. 2005 Nov 15;104(10):2244-54.

Kupelian PA, Ramsey C, Meeks SL, Willoughby TR, Forbes A, Wagner TH, Langen KM.
Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: Observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1024-8.

Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, Arusell RM, Shaw EG, Buckner JC.
Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1175-83.

Ritoe SC, Bergman H, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA.
Cancer recurrence after total laryngectomy: Treatment options, survival, and complications. Head Neck. 2005 Nov 14;

Rabinovitch R, Grant B, Berkey BA, Raben D, Ang KK, Fu KK, Cooper JS.
Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90-03. Head Neck. 2005 Nov 14;

Stephenson AJ, Eastham JA.
Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol. 2005 Nov 10;23(32):8198-203.

Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Marti JL, Lobo F, Pastor P, Valenti V, Belon J, Sanchez MA, Chaib C, Pallares C, Anton A, Cervantes A, Paz-Ares L, Cortes-Funes H.
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer. J Clin Oncol. 2005 Nov 7;

Hashine K, Numata K, Azuma K, Sumiyoshi Y, Kataoka M.
Long-Term Outcomes of 60 Gy Conventional Radiotherapy Combined with Androgen Deprivation for Localized or Locally Advanced Prostate Cancer. Jpn J Clin Oncol. 2005 Nov 7;

Christian JA, Partridge M, Nioutsikou E, Cook G, McNair HA, Cronin B, Courbon F, Bedford JL, Brada M.
The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. Radiother Oncol. 2005 Nov 3;

Christie D, Denham J, Steigler A, Lamb D, Turner S, Mameghan H, Joseph D, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, Francis L, Kramar A, D'Este C, Bill D.
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation. Radiother Oncol. 2005 Nov 3;

Pinkawa M, Fischedick K, Treusacher P, Asadpour B, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ.
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer- a phase II study. Radiother Oncol. 2005 Nov 3;

Aoki M, Abe Y, Hatayama Y, Kondo H, Basaki K.
Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation. Int J Radiat Oncol Biol Phys. 2005 Nov 2;

Goldner G, Zimmermann F, Feldmann H, Glocker S, Wachter-Gerstner N, Geinitz H, Becker G, Potzi R, Wambersie A, Bamberg M, Molls M, Wachter S, Potter R.
3-D conformal radiotherapy of localized prostate cancer: A subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects. Radiother Oncol. 2005 Nov 2;

Mansur DB, Kong FM, El Naqa I, Taylor ME, Zoberi I, Bradley JD, Perez CA, Klein EE.
CT localization of axillary lymph nodes in relation to the humeral head: Significance of arm position for radiation therapy planning. Radiother Oncol. 2005 Nov 2;

Pipas JM, Barth RJ Jr, Zaki B, Tsapakos MJ, Suriawinata AA, Bettmann MA, Cates JM, Ripple GH, Sutton JE, Gordon SR, McDonnell CE, Perez RP, Redfield N, Meyer LP, Marshall JF, Cole BF, Colacchio TA.
Docetaxel/Gemcitabine Followed by Gemcitabine and External Beam Radiotherapy in Patients With Pancreatic Adenocarcinoma. Ann Surg Oncol. 2005 Nov 1;

Menes TS, Tartter PI, Bleiweiss I, Godbold JH, Estabrook A, Smith SR.
The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol. 2005 Nov;12(11):881-5. Epub 2005 Oct 3.

Terai A, Matsui Y, Yoshimura K, Arai Y, Dodo Y.
Salvage radiotherapy for biochemical recurrence after radical prostatectomy. BJU Int. 2005 Nov;96(7):1009-13.

Rapp DE, Orvieto MA, Lucioni A, Gong EM, Shalhav AL, Brendler CB.
Intra-operative prostate examination: predictive value and effect on margin status. BJU Int. 2005 Nov;96(7):1005-8.

Richtig E, Ludwig R, Kerl H, Smolle J.
Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma. Br J Dermatol. 2005 Nov;153(5):925-31.

Kuo SJ, Yang KT, Chen DR.
Objective and noninvasive detection of sub-clinical lung injury in breast cancer patients after radiotherapy. Eur J Surg Oncol. 2005 Nov;31(9):954-7.

Lin K, Patel SG, Chu PY, Matsuo JM, Singh B, Wong RJ, Kraus DH, Shaha AR, Shah JP, Boyle JO.
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck. 2005 Nov 1;27(12):1042-1048

Berthelet E, Pickles T, Lee KW, Liu M, Truong PT; Prostate Cancer Outcomes Initiative.
Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels >20 ng/mL. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):781-7.

Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D.
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. Epub 2005 May 31.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

Lester JF, Macbeth FR, Coles B.
Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: A Cochrane Review. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):690-4.

Kaufmann M, Graf E, Jonat W, Eiermann W, Geberth M, Albert US, Gademann G, Conrad B, Stahl K, von Minckwitz G, Schumacher M; German Adjuvant Breast Cancer Group.
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group. J Clin Oncol. 2005 Nov 1;23(31):7842-8.

Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll PR.
Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE. J Urol. 2005 Nov;174(5):1802-7.

Denham JW, Steigler A, Lamb DS, Joseph D, Mameghan H, Turner S, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Christie D, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, D'Este C.
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol. 2005 Nov;6(11):841-50.

Ruffer JU, Ballova V, Glossmann J, Sieber M, Franklin J, Nogova L, Diehl V, Josting A.
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - Results of the German Hodgkin Study Group. Leuk Lymphoma. 2005 Nov;46(11):1561-7.

Metellus P, Regis J, Muracciole X, Fuentes S, Dufour H, Nanni I, Chinot O, Martin PM, Grisoli F.
Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery. 2005 Nov;57(5):873-86; discussion 873-86.

Poetker DM, Jursinic PA, Runge-Samuelson CL, Wackym PA.
Distortion of Magnetic Resonance Images Used in Gamma Knife Radiosurgery Treatment Planning: Implications for Acoustic Neuroma Outcomes. Otol Neurotol. 2005 Nov;26(6):1220-1228.

Iwai Y, Yamanaka K, Yoshimura M.
Gamma knife radiosurgery for cavernous sinus metastases and invasion. Surg Neurol. 2005 Nov;64(5):406-10.

Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ.
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov;66(5):1060-5.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E.
Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy. Urology. 2005 Nov;66(5):1048-53.

Pelzer AE, Tewari A, Bektic J, Berger AP, Frauscher F, Bartsch G, Horninger W.
Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project. Urology. 2005 Nov;66(5):1029-33.

Dvorak T, Chen MH, Renshaw AA, Loffredo M, Richie JP, D'Amico AV.
Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer. Urology. 2005 Nov;66(5):1024-8.

Beard C, Chen MH, Cote K, Loffredo M, Renshaw A, Hurwitz M, D'Amico AV.
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer. Urology. 2005 Nov;66(5):1020-3.

Rubin MA, Allory Y, Molinie V, Leroy X, Faucon H, Vacherot F, Huang W, Kuten A, Salomon L, Rebillard X, Cussenot O, Abbou C, de la Taille A.
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome. Urology. 2005 Nov;66(5):930-4.

Menon M, Shrivastava A, Tewari A.
Laparoscopic radical prostatectomy: conventional and robotic. Urology. 2005 Nov;66(5 Suppl):101-4.

Dussinger AM, Beck SD, Cheng L, Koch MO.
Does wide primary perirectal dissection during radical retropubic prostatectomy alter pathologic and biochemical outcomes? Urology. 2005 Nov;66(5 Suppl):95-100.

October

Bianco FJ Jr, Scardino PT, Eastham JA.
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology. 2005 Nov;66(5 Suppl):83-94.

Richtig E, Soyer HP, Posch M, Mossbacher U, Bauer P, Teban L, Svolba G, Wolf IH, Fritsch P, Zelger B, Volc-Platzer B, Gebhart W, Mischer P, Steiner A, Pachinger W, Hintner H, Gschnait F, Rappersberger K, Pilarski P, Pehamberger H.
Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Trial Comparing Adjuvant Interferon Alfa and Isotretinoin With Interferon Alfa Alone in Stage IIA and IIB Melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group. J Clin Oncol. 2005 Oct 31;

Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'callaghan CJ, Francini G, Grothey A, O'connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A.
Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials. J Clin Oncol. 2005 Oct 31;

Aparicio J, Germa JR, Del Muro XG, Maroto P, Arranz JA, Saenz A, Barnadas A, Dorca J, Guma J, Olmos D, Bastus R, Carles J, Almenar D, Sanchez M, Paz-Ares L, Satrustegui JJ, Mellado B, Balil A, Lopez-Brea M, Sanchez A.
Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study. J Clin Oncol. 2005 Oct 31;

Delanian S, Porcher R, Rudant J, Lefaix JL.
Kinetics of Response to Long-Term Treatment Combining Pentoxifylline and Tocopherol in Patients With Superficial Radiation-Induced Fibrosis. J Clin Oncol. 2005 Oct 31;

Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB.
Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer. 2005 Oct 24;

Tham IW, Lee KM, Peng Yap S, Loong SL.
Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy. Head Neck. 2005 Oct 20;

van Tol-Geerdink JJ, Stalmeier PF, Pasker-de Jong PC, Huizenga H, van Lin EN, Schimmel EC, Leer JW, van Daal WA.
Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT. Int J Radiat Oncol Biol Phys. 2005 Oct 20;

Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T; Children's Cancer Group.
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol. 2005 Oct 20;23(30):7621-31.

Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, Tennis M, Czene K.
Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol. 2005 Oct 20;23(30):7467-74.

Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, Hortobagyi GN, Giordano SH.
Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005 Oct 20;23(30):7475-82.

Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS, Wong R, Siu LL, Moore M, Brierley J.
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys. 2005 Oct 18;

Lanciano R, Calkins A, Bundy BN, Parham G, Lucci Iii JA, Moore DH, Monk BJ, O'connor DM.
A Randomized Comparison of Weekly Cisplatin or Protracted Venous Infusion of Fluorouracil in Combination With Pelvic Radiation in Advanced Cervix Cancer: A Gynecologic Oncology Group Study. J Clin Oncol. 2005 Oct 17;

Lim L, Gibbs P, Yip D, Shapiro JD, Dowling R, Smith D, Little A, Bailey W, Liechtenstein M.
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer. 2005 Oct 15;5:132.

Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB.
12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys. 2005 Oct 12;

Arcangeli G, Pinnaro P, Rambone R, Giannarelli D, Benassi M.
A Phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005 Oct 11;

Wang Y, Cummings B, Catton P, Dawson L, Kim J, Ringash J, Wong R, Yi QL, Brierley J.
Primary radical external beam radiotherapy of rectal adenocarcinoma: Long term outcome of 271 patients. Radiother Oncol. 2005 Oct 7;

Barker CA, Morris CG, Mendenhall WM.
Larynx-sparing radiotherapy for squamous cell carcinoma from an unknown head and neck primary site. Am J Clin Oncol. 2005 Oct;28(5):445-8.

Nogova L, Reineke T, Eich HT, Josting A, Muller-Hermelink HK, Wingbermuhle K, Brillant C, Gossmann A, Oertel J, Bollen MV, Muller RP, Diehl V, Engert A.
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol. 2005 Oct;16(10):1683-7.

Kilic E, Stijnen T, de Jong PT, Mooy CM, Eijkenboom WM, Ringens PJ, Luyten GP.
Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy. Arch Ophthalmol. 2005 Oct;123(10):1363-7.

van Ginderdeuren R, van Limbergen E, Spileers W.
18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma. Br J Ophthalmol. 2005 Oct;89(10):1306-10.

Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefebvre JL.
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005 Oct;27(10):843-50.

Uchida T, Baba S, Irie A, Soh S, Masumori N, Tsukamoto T, Nakatsu H, Fujimoto H, Kakizoe T, Ueda T, Ichikawa T, Ohta N, Kitamura T, Sumitomo M, Hayakawa M, Aoyagi T, Tachibana M, Ikeda R, Suzuki K, Tsuru N, Suzuki K, Ozono S, Fujimoto K, Hirao Y, Monden K, Nasu Y, Kumon H, Nishi K, Ueda S, Koga H, Naitoh S.
Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study. Hinyokika Kiyo. 2005 Oct;51(10):651-8.

van Lin EN, Hoffmann AL, van Kollenburg P, Leer JW, Visser AG.
Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):565-76.

Grosu AL, Weber WA, Franz M, Stark S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9.

Weber DC, Bogner J, Verwey J, Georg D, Dieckmann K, Escude L, Caro M, Potter R, Goitein G, Lomax AJ, Miralbell R.
Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):373-84.

Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ.
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):354-61.

Gruber G, Bonetti M, Nasi ML, Price KN, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, Lindtner J, Golouh R, Collins J, Crivellari D, Carbone A, Thurlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group.
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI. J Clin Oncol. 2005 Oct 1;23(28):7089-97.

Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV.
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol. 2005 Oct 1;23(28):6992-8.

Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, Siu L, Sze WM, Leung TW, Sham JS, Ngan RK, Law SC, Yau TK, Au JS, O'Sullivan B, Pang ES, O SK, Au GK, Lau JT; Hong Kong Nasopharyngeal Cancer Study Group.
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol. 2005 Oct 1;23(28):6966-75.

Emerson RE, Koch MO, Jones TD, Daggy JK, Juliar BE, Cheng L.
The influence of extent of surgical margin positivity on prostate specific antigen recurrence. J Clin Pathol. 2005 Oct;58(10):1028-32.

Yilmaz T, Hosal S, Ozyar E, Akyol F, Gursel B.
Post-operative radiotherapy in advanced laryngeal cancer: effect on local and regional recurrence, distant metastases and second primaries. J Laryngol Otol. 2005 Oct;119(10):784-90.

Stolzenburg JU, Rabenalt R, DO M, Ho K, Dorschner W, Waldkirch E, Jonas U, Schutz A, Horn L, Truss MC.
Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures. J Urol. 2005 Oct;174(4 Pt 1):1271-5; discussion 1275.

Kamat AM, Jacobsohn KM, Troncoso P, Shen Y, Wen S, Babaian RJ.
Validation of criteria used to predict extraprostatic cancer extension: a tool for use in selecting patients for nerve sparing radical prostatectomy. J Urol. 2005 Oct;174(4 Pt 1):1262-5.

Eggermont AM, Suciu S, MacKie R, Ruka W, Testori A, Kruit W, Punt CJ, Delauney M, Sales F, Groenewegen G, Ruiter DJ, Jagiello I, Stoitchkov K, Keilholz U, Lienard D; EORTC Melanoma Group.
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial. Lancet. 2005 Oct 1;366(9492):1189-96.

Roberge D, Parker W, Niazi TM, Olivares M.
Treating the contents and not the container: dosimetric study of hair-sparing whole brain intensity modulated radiation therapy. Technol Cancer Res Treat. 2005 Oct;4(5):567-70.

Cohen MH, Johnson JR, Pazdur R.
Food and drug administration drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6767-71.

Liauw SL, Amdur RJ, Mendenhall WM, Palta J, Kim S.
The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer. Am J Clin Oncol. 2005 Oct;28(5):456-9.

Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, Chafe S, Arthur D, Petersen I, McCormick B.
A Phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: Initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys. 2005 Sep 27;

Ray ME, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA.
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis. Int J Radiat Oncol Biol Phys. 2005 Sep 27;

Chen M, Hayman JA, Ten Haken RK, Tatro D, Fernando S, Kong FM.
Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys. 2005 Sep 27;

Sanguineti G, Cavey ML, Endres EJ, Brandon GG, Bayouth JE.
Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer? Int J Radiat Oncol Biol Phys. 2005 Sep 27;

Menes TS, Tartter PI, Bleiweiss I, Godbold JH, Estabrook A, Smith SR.
The Consequence of Multiple Re-Excisions to Obtain Clear Lumpectomy Margins in Breast Cancer Patients. Ann Surg Oncol. 2005 Oct 3;

Menon M, Shrivastava A, Tewari A.
Laparoscopic radical prostatectomy: conventional and robotic. Urology. 2005 Nov;66(5 Suppl):101-4.

Bianco FJ Jr, Scardino PT, Eastham JA.
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology. 2005 Nov;66(5 Suppl):83-94.

Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, Siu L, Sze WM, Leung TW, Sham JS, Ngan RK, Law SC, Yau TK, Au JS, O'sullivan B, Pang ES, O SK, Au GK, Lau JT.
Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol. 2005 Oct 1;23(28):6966-75.

Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, Ullmer L, Gallagher A, Cullen J, Gehan E, Hayes DF, Isaacs C.
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol. 2005 Oct 1;23(28):6919-30.

Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, Hwu P, Zagars GK.
Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys. 2005 Sep 20;

Beal K, Hudis C, Norton L, Wagman R, McCormick B.
Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk? Breast J. 2005 Sep-Oct;11(5):317-20.

Bhatnagar AK, Gerszten PC, Ozhasaglu C, Vogel WJ, Kalnicki S, Welch WC, Burton SA.
CyberKnife Frameless Radiosurgery for the Treatment of Extracranial Benign Tumors. Technol Cancer Res Treat. 2005 Oct;4(5):571-6.

Reyns N, Hayashi M, Chinot O, Manera L, Peragut JC, Blond S, Regis J.
The role of Gamma Knife radiosurgery in the treatment of pineal parenchymal tumours. Acta Neurochir (Wien). 2005 Sep 19;

Kim TH, Kim DY, Cho KH, Kim YH, Jung KH, Ahn JB, Chang HJ, Kim JY, Choi HS, Lim SB, Sohn DK, Jeong SY.
Comparative Analysis of the Effects of Belly Board and Bladder Distension in Postoperative Radiotherapy of Rectal Cancer Patients. Strahlenther Onkol. 2005 Sep;181(9):601-605.

Dorr W, Bertmann S, Herrmann T.
Radiation Induced Lung Reactions in Breast Cancer Therapy Modulating Factors and Consequential Effects. Strahlenther Onkol. 2005 Sep;181(9):567-573.

Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D.
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005 Sep 20;23(27):6730-8.

Zapatero A, Valcarcel F, Calvo FA, Algas R, Bejar A, Maldonado J, Villa S.
Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study. J Clin Oncol. 2005 Sep 20;23(27):6561-8.

Bowers DC, McNeil DE, Liu Y, Yasui Y, Stovall M, Gurney JG, Hudson MM, Donaldson SS, Packer RJ, Mitby PA, Kasper CE, Robison LL, Oeffinger KC.
Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2005 Sep 20;23(27):6508-15.

Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M.
Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2005 Sep 15;

Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD.
Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Sep 15;

Grosu AL, Weber WA, Franz M, Stark S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9.

Weber DC, Bogner J, Verwey J, Georg D, Dieckmann K, Escude L, Caro M, Potter R, Goitein G, Lomax AJ, Miralbell R.
Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):373-84.

Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ.
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):354-61.

Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA.
High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):324-33.

Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP.
Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):320-3.

September

van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmstrom PO, Collette L, Pierart M, Mirimanoff R, Karim AB; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council.
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005 Sep 17;366(9490):985-90.

Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefebvre JL.
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005 Oct;27(10):843-50.

Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, Shipley WU.
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005 Sep 14;294(10):1233-9.

Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, Hortobagyi GN, Giordano SH.
Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer. J Clin Oncol. 2005 Sep 12;

Suwinski R, Bankowska-Wozniak M, Majewski W, Sowa A, Idasiak A, Ziolkowska E, Windorbska W, Tarnawski R, Skladowski K, Maciejewski B.
Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: A report on acute normal tissue reactions. Radiother Oncol. 2005 Sep 9;

Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA, Eisbruch A.
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol. 2005 Sep 7;

Maranzano E, Feyer PC, Molassiotis A, Rossi R, Clark-Snow RA, Olver I, Warr D, Schiavone C, Roila On Behalf Of Participants In The Perugia Consensus Conference 2004 F.
Evidence-based recommendations for the use of antiemetics in radiotherapy. Radiother Oncol. 2005 Sep;76(3):227-233.

Masterson TA, Stephenson AJ, Scardino PT, Eastham JA.
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology. 2005 Sep;66(3):623-6.

Jani AB, Gratzle J.
Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapy. Urology. 2005 Sep;66(3):566-70.

Soderdahl DW, Diaz JI, Rabah DM, Schellhammer PF, Fabrizio MD.
Laparoscopic radical prostatectomy: evaluation of specimen pathologic features to critically assess and modify surgical technique. Urology. 2005 Sep;66(3):552-6.

Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; for the Institut Curie Breast Cancer Study Group.
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer. 2005 Aug 31;

Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA.
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol. 2005 Sep 1;23(25):6199-206.

Patel DA, Presti JC Jr, McNeal JE, Gill H, Brooks JD, King CR.
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. J Clin Oncol. 2005 Sep 1;23(25):6157-62.

Lukka H, Hayter C, Julian JA, Warde P, Morris WJ, Gospodarowicz M, Levine M, Sathya J, Choo R, Prichard H, Brundage M, Kwan W.
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol. 2005 Sep 1;23(25):6132-8.

Birgisson H, Pahlman L, Gunnarsson U, Glimelius B.
Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol. 2005 Sep 1;23(25):6126-31.

Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol. 2005 Sep 20;23(27):6533-9. Epub 2005 Aug 22.

Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ, van der Sangen MJ, Botke G, Hoekstra CJ, Jobsen JJ, van de Velde CJ, von Meyenfeldt MF, Tabak JM, Peterse JL, van de Vijver MJ, Coebergh JW, van Tienhoven G; for the Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group).
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer. 2005 Aug 19;

Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Biti G.
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two italian radiation oncology centers. II. the case of T2N0 disease. Int J Radiat Oncol Biol Phys. 2005 Aug 19;

Hong TS, Kriesel KJ, Hartig GK, Harari PM.
Parotid area lymph node metastases from cutaneous squamous cell carcinoma: Implications for diagnosis, treatment, and prognosis. Head Neck. 2005 Oct;27(10):851-6.

Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY.
Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):274-81.

Muller K, Nowak PJ, de Pan C, Marijnissen JP, Paridaens DA, Levendag P, Luyten GP.
Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):116-22.

Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD.
Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):109-15.

Henson CF, Goldman HW, Rosenwasser RH, Downes MB, Bednarz G, Pequignot EC, Werner-Wasik M, Curran WJ, Andrews DW.
Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):82-90.

Tsao MN, Mehta MP, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L.
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):47-55.

Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L.
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46.

Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U.
Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005 Aug 20;23(24):5644-50.

Jawahar A, Shaya M, Campbell P, Ampil F, Willis BK, Smith D, Nanda A.
Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases. Surg Neurol. 2005 Sep;64(3):207-12.

Trouncer RJ, Rowbottom CG, Budgell GJ, Mackay RI, Magee B.
Intensity-modulated radiotherapy planning from limited anatomical information: is Sim-CT sufficient for planning women with breast cancer receiving intensity-modulated radiotherapy? Clin Oncol (R Coll Radiol). 2005 Aug;17(5):343-51.

Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Pollim D C, Livi L, Bonetti B, Vitalim D E, De Stefani A, Buglione M, Biti G.
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two italian radiation oncology centers. I. the case of T1N0 disease. Int J Radiat Oncol Biol Phys. 2005 Aug 9;

Fournel P, Robinet G, Thomas P, Souquet PJ, Lena H, Vergnenegre A, Delhoume JY, Le Treut J, Silvani JA, Dansin E, Bozonnat MC, Daures JP, Mornex F, Perol M; Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie.
Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol. 2005 Sep 1;23(25):5910-7. Epub 2005 Aug 8.

Rhomberg W, Eiter H, Boehler F, Saely C, Strohal R.
Combined razoxane and radiotherapy for melanoma brain metastases. A retrospective analysis. J Neurooncol. 2005 Sep;74(3):295-9.

Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rube C, Kirsch CM.
Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med. 2005 Aug;46(8):1342-8.

Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R.
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol. 2005 Aug;28(4):371-8.

Darby SC, McGale P, Taylor CW, Peto R.
Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005 Aug;6(8):557-65.

Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH.
The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1432-7.

Cohen SJ, Dobelbower R Jr, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG; Eastern Cooperative Oncology Group.
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1345-50.

Vass S, Bairati I.
A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1274-82.

Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A.
Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer. 2005 Aug 15;104(4):856-63.

Mehta V.
Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):5-24.

Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM.
Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):683-9. Epub 2005 May 31.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

Lester JF, Macbeth FR, Coles B.
Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: A Cochrane Review. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):690-4.

Stephens RJ, Girling DJ, Hopwood P, Thatcher N; Medical Research Council Lung Cancer Working Party.
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer. Lung Cancer. 2005 Sep;49(3):395-400.

Antoniou D, Kyprianou K, Stathopoulos GP, Skarleas C, Kolitsi G, Veslemes M, Dimitroulis J, Giamboudakis P, Marosis K, Armenaki O, Papageorgiou C, Katis C.
Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer. Oncol Rep. 2005 Sep;14(3):733-6.

Muacevic A, Siebels M, Tonn JC, Wowra B.
Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? World J Urol. 2005 Sep;23(3):180-4.

August

Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A.
Radiation-induced sarcomas after radiotherapy for breast carcinoma. Cancer. 2005 Aug 15;104(4):856-63.

Tsougos I, Mavroidis P, Rajala J, Theodorou K, Jarvenpaa R, Pitkanen MA, Holli K, Ojala AT, Lind BK, Hyodynmaa S, Kappas C.
Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Phys Med Biol. 2005 Aug 7;50(15):3535-54.

Gupta T.
Stereotactic radiosurgery for brain oligometastases: good for some, better for all? Ann Oncol. 2005 Aug 5;

Sturgis EM, Moore BA, Glisson BS, Kies MS, Shin DM, Byers RM.
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: A case series. Head Neck. 2005 Aug 5;

Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP.
The Effect of Sentinel Node Tumor Burden on Non-Sentinel Node Status and Recurrence Rates in Breast Cancer. Ann Surg Oncol. 2005 Aug 4;

Schaller C, Liefner M, Ansari S, Al Moutaery K.
Operation for delayed symptomatic brain oedema after treatment of an arteriovenous malformation by embolization and radiosurgery. Acta Neurochir (Wien). 2005 Aug 3;

Henry LR, Sigurdson E, Ross E, Hoffman JP.
Hydronephrosis Does Not Preclude Curative Resection of Pelvic Recurrences After Colorectal Surgery. Ann Surg Oncol. 2005 Aug 3;

Hyun Kim T, Choi J, Park SY, Lee SH, Lee KC, Yang DS, Shin KH, Cho KH, Lim HS, Kim JY.
Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. Cancer. 2005 Aug 2;

Huston TL, Simmons RM.
Inflammatory local recurrence after breast-conservation therapy for noninflammatory breast cancer. Am J Clin Oncol. 2005 Aug;28(4):431-2.

Hazard LJ, Jensen RL, Shrieve DC.
Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clin Oncol. 2005 Aug;28(4):403-10.

Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R.
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol. 2005 Aug;28(4):371-8.

Pacholke HD, Amdur RJ, Morris CG, Li JG, Dempsey JF, Hinerman RW, Mendenhall WM.
Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol. 2005 Aug;28(4):351-8.

Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ.
Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005 Aug;12(8):654-9.

Truong PT, Berthelet E, Patenaude V, Bishop J, Sandwith B, Moravan V, Beckham W, Mitchell T, Olivotto IA.
Setup variations in locoregional radiotherapy for breast cancer: an electronic portal imaging study. Br J Radiol. 2005 Aug;78(932):742-5.

Paek SH, Chung HT, Jeong SS, Park CK, Kim CY, Kim JE, Kim DG, Jung HW.
Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer. 2005 Aug 1;104(3):580-90.

Johnson LB, Jorgensen LN, Adawi D, Blomqvist P, Asklof GB, Gottrup F, Jeppsson B.
The effect of preoperative radiotherapy on systemic collagen deposition and postoperative infective complications in rectal cancer patients. Dis Colon Rectum. 2005 Aug;48(8):1573-80.

Jahraus CD, Rubin DT, Scherl EJ, Bettenhausen D.
Inflammation's Role in Rectal Cancer Following Prostate Radiotherapy, and Emerging Evidence for a Protective Role for Balsalazide. Gastroenterology. 2005 Aug;129(2):770-2.

Ballo MT, Garden AS, Myers JN, Lee JE, Diaz EM Jr, Sturgis EM, Morrison WH, Gershenwald JE, Ross MI, Weber RS, Ang KK.
Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease? Head Neck. 2005 Aug;27(8):718-21.

Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME.
Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005 Aug;27(8):659-68.

Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH.
The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1432-7.

Pollock BE, Stafford SL.
Results of stereotactic radiosurgery for patients with imaging defined cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1427-31.

Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD.
Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1405-1411.

Cohen SJ, Dobelbower R Jr, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG.
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1345-50.

Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308.

Vass S, Bairati I.
A cosmetic evaluation of breast cancer treatment: A randomized study of radiotherapy boost technique. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1274-82.

Beebe DW, Ris MD, Armstrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH.
Cognitive and Adaptive Outcome in Low-Grade Pediatric Cerebellar Astrocytomas: Evidence of Diminished Cognitive and Adaptive Functioning in National Collaborative Research Studies (CCG 9891/POG 9130). J Clin Oncol. 2005 Aug 1;23(22):5198-204.

Hayman JA, Kabeto MU, Schipper MJ, Bennett JE, Vicini FA, Pierce LJ.
Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ. J Clin Oncol. 2005 Aug 1;23(22):5171-7.

Smith IE, Dowsett M, Ebbs SR, Dixon JM, Skene A, Blohmer JU, Ashley SE, Francis S, Boeddinghaus I, Walsh G.
Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial. J Clin Oncol. 2005 Aug 1;23(22):5108-16.

Sandalcioglu IE, Gasser T, Mohr C, Stolke D, Wiedemayer H.
Spheno-orbital meningiomas: interdisciplinary surgical approach, resectability and long-term results. J Craniomaxillofac Surg. 2005 Aug;33(4):260-6.

Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rube C, Kirsch CM.
Comparison of Different Methods for Delineation of 18F-FDG PET-Positive Tissue for Target Volume Definition in Radiotherapy of Patients with Non-Small Cell Lung Cancer. J Nucl Med. 2005 Aug;46(8):1342-8.

Duffau H.
Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. Lancet Neurol. 2005 Aug;4(8):476-86.

Darby SC, McGale P, Taylor CW, Peto R.
Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol. 2005 Aug;6(8):557-65.

Turkolmez S, Atasever T, Akmansu M.
Effects of radiation therapy on oesophageal transit in patients with inner quadrant breast tumour. Nucl Med Commun. 2005 Aug;26(8):721-6.

Schueller P, Micke O, Palkovic S, Schroeder J, Moustakis C, Bruns F, Schuck A, Wassmann H, Willich N.
12 Years' Experience with Intraoperative Radiotherapy (IORT) of Malignant Gliomas. Strahlenther Onkol. 2005 Aug;181(8):500-506.

July

Rhomberg W, Eiter H, Boehler F, Saely C, Strohal R.
Combined Razoxane and Radiotherapy for Melanoma Brain Metastases. A Retrospective Analysis. J Neurooncol. 2005 Jul 30;

Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer M, Storm H, Pukkala E, Stovall M, Curtis RE, Allan JM, Boice JD, Travis LB.
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood. 2005 Jul 28;

D'Amico AV, Renshaw AA, Sussman B, Chen MH.
Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA. 2005 Jul 27;294(4):440-7.

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW.
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005 Jul 27;294(4):433-9.

Solin LJ, Fourquet A, Vicini FA, Taylor M, Haffty B, Strom EA, Wai E, Pierce LJ, Marks LB, Bartelink H, Campana F, McNeese MD, Jhingran A, Olivotto IA, Bijker N, Hwang WT.
Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer. 2005 Jul 22;

Haffner MC, Landis PK, Saigal CS, Carter HB, Freedland SJ.
Health-related Quality-of-life Outcomes after Anatomic Retropubic Radical Prostatectomy in the Phosphodiesterase Type 5 Era: Impact of Neurovascular Bundle Preservation. Urology. 2005 Jul 22;

Naya Y, Okihara K, Evans RB, Babaian RJ.
Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy. Urology. 2005 Jul 22;

Epstein JI, Sanderson H, Carter HB, Scharfstein DO.
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology. 2005 Jul 22;

Rosser CJ, Kamat AM, Wang X, Do KA, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL.
Is Patient Age a Factor in the Occurrence of Prostate-Specific Antigen Bounce Phenomenon After External Beam Radiotherapy for Prostate Cancer? Urology. 2005 Jul 22;

Scarbrough TJ, Crocker IR, Davis LW, Barrow DL, Fowler BZ, Oyesiku NM.
Intracranial Arteriovenous Malformations Treated Utilizing a Linear Accelerator-Based Patient Rotator or Commercially Available Radiosurgery System. Stereotact Funct Neurosurg. 2005 Jul 19;83(2-3):91-100

Bairati I, Meyer F, Gelinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Tetu B, Harel F, Abdous B, Vigneault E, Vass S, Del Vecchio P, Roy J.
A Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients. J Clin Oncol. 2005 Jul 18;

Fuss M, Salter BJ, Caron JL, Vollmer DG, Herman TS.
Intensity-modulated radiosurgery for childhood arteriovenous malformations. Acta Neurochir (Wien). 2005 Jul 15; [

Furuse M, Miyatake SI, Kuroiwa T.	Related Articles, Books, LinkOut
Cavernous malformation after radiation therapy for astrocytoma in adult patients: report of 2 cases. Acta Neurochir (Wien). 2005 Jul 15;

Benchalal M, Le Prise E, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P.
Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery. Cancer. 2005 Jul 15;104(2):240-50.

Noel G, Bollet MA, Noel S, Feuvret L, Boisserie G, Tep B, Delattre JY, Baillet F, Ambroise Valery C, Cornu P, Mazeron JJ.
Linac stereotactic radiosurgery: An effective and safe treatment for elderly patients with brain metastases. Int J Radiat Oncol Biol Phys. 2005 Jul 15;

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.
Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD.
The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1125-32.

Aoyama H, Shirato H, Katoh N, Kudo K, Asano T, Kuroda S, Ishikawa T, Miyasaka K.
Comparison of imaging modalities for the accurate delineation of arteriovenous malformation, with reference to stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1232-8.

Claude L, Perol D, Ray-Coquard I, Petit T, Blay JY, Carrie C, Bachelot T.
Lymphopenia: A new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Radiother Oncol. 2005 Jul 14;

Sharifi N, Gulley JL, Dahut WL.
Androgen deprivation therapy for prostate cancer. JAMA. 2005 Jul 13;294(2):238-44.

Villeirs GM, L Verstraete K, De Neve WJ, De Meerleer GO.
Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. Radiother Oncol. 2005 Jul 12;

Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L.
Enhanced Tumorocidal Effect of Preoperative Radiotherapy on Rectal Cancer by Adding Chemotherapy: Preliminary Results From the 22921 European Organisation for Research and Treatment of Cancer Randomized Trial. J Clin Oncol. 2005 Jul 11;

Ruysscher DD, Wanders S, Minken A, Lumens A, Schiffelers J, Stultiens C, Halders S, Boersma L, Baardwijk AV, Verschueren T, Hochstenbag M, Snoep G, Wouters B, Nijsten S, Bentzen SM, Kroonenburgh MV, Ollers M, Lambin P.
Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study. Radiother Oncol. 2005 Jul 11;

Willett CG, Czito BG, Bendell JC, Ryan DP.
Locally advanced pancreatic cancer. J Clin Oncol. 2005 Jul 10;23(20):4538-44. Review.

Chua YJ, Cunningham D.
Adjuvant treatment for resectable pancreatic cancer. J Clin Oncol. 2005 Jul 10;23(20):4532-7. Review.

Jansen EP, Boot H, Verheij M, van de Velde CJ.
Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005 Jul 10;23(20):4509-17. Review.

Wasif Saif M, Moody JS, Russo SM.
Gastrointestinal bleeding associated with concurrent capecitabine and radiotherapy in patients with pancreatic cancer.
Albertsen PC, Hanley JA, Fine J.
20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005 May 4;293(17):2095-101.

Atallah E, Flaherty L.
Treatment of metastatic malignant melanoma. Curr Treat Options Oncol. 2005 May;6(3):185-93.

Sadetzki S, Oberman B, Zipple D, Kaufman B, Rizel S, Novikov I, Papa AM.
Breast Conservation After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2005 Apr 19;

Gridelli C, Aapro M, Ardizzoni A, Balducci L, De Marinis F, Kelly K, Le Chevalier T, Manegold C, Perrone F, Rosell R, Shepherd F, De Petris L, Di Maio M, Langer C.
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. J Clin Oncol. 2005 May 1;23(13):3125-37.

Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW.
Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005 May 1;23(13):3079-85.

Roh JL, Kim AY, Cho MJ.
Xerostomia following radiotherapy of the head and neck affects vocal function. J Clin Oncol. 2005 May 1;23(13):3016-23.

Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Deapen D, Salem B, Lakhani I, Morrow M.
Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol. 2005 May 1;23(13):3001-7.

Cheng L, Koch MO, Juliar BE, Daggy JK, Foster RS, Bihrle R, Gardner TA.
The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol. 2005 May 1;23(13):2911-7.

Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW.
Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery. 2005 May;56(5):1021-34; discussion 1021-34.

Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A, Sawaya R, Woo SY.
Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005 May;56(5):936-45; discussion 936-45.

Myrseth E, Moller P, Pedersen PH, Vassbotn FS, Wentzel-Larsen T, Lund-Johansen M.
Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery. 2005 May;56(5):927-35; discussion 927-35.

Buis DR, Lagerwaard FJ, Barkhof F, Dirven CM, Lycklama GJ, Meijer OW, van den Berg R, Langendijk HA, Slotman BJ, Vandertop WP.
Stereotactic radiosurgery for brain AVMs: Role of interobserver variation in target definition on digital subtraction angiography. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):246-52.

Mullins D, Proulx D, Saoudi A, Ng CE.
Chronomodulation of topotecan or X-radiation treatment increases treatment efficacy without enhancing acute toxicity. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):230-7.

Goodman KA, Toner S, Hunt M, Wu EJ, Yahalom J.
Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):198-206.

Pierce LJ, Moughan J, White J, Winchester DP, Owen J, Wilson JF.
1998-1999 Patterns of Care Study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of Stage I-II breast cancer. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):183-92.

Truong PT, Lesperance M, Culhaci A, Kader HA, Speers CH, Olivotto IA.
Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):175-182.

Wallner K, Merrick G, Sutlief S, True L, Butler W.
High-dose regions versus likelihood of cure after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):170-4.

Elshaikh MA, Ulchaker JC, Reddy CA, Angermeier KW, Klein EA, Chehade N, Altman A, Ciezki JP.
Prophylactic tamsulosin (Flomax) in patients undergoing prostate (125)I brachytherapy for prostate carcinoma: Final report of a double-blind placebo-controlled randomized study. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):164-9.

Bates AT, Pickles T, Paltiel C.
PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):148-53.

Frank SJ, Jhingran A, Levenback C, Eifel PJ.
Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):138-47.

Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ.
Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):131-7.

Molla M, Escude L, Nouet P, Popowski Y, Hidalgo A, Rouzaud M, Linero D, Miralbell R.
Fractionated stereotactic radiotherapy boost for gynecologic tumors: An alternative to brachytherapy? Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):118-24.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.
Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

Xiao ZF, Yang ZY, Miao YJ, Wang LH, Yin WB, Gu XZ, Zhang DC, Sun KL, Chen GY, He J.
Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: Report of 549 cases. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):82-90.

Fox JL, Rengan R, O'meara W, Yorke E, Erdi Y, Nehmeh S, Leibel SA, Rosenzweig KE.
Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):70-5.

Terhaard CH, Kal HB, Hordijk GJ.
Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):62-9.

Yamada Y, Lovelock DM, Yenice KM, Bilsky MH, Hunt MA, Zatcky J, Leibel SA.
Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: A preliminary report. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):53-61.

Zhang P, Brisman R, Choi J, Li X.
Where to locate the isocenter? The treatment strategy for repeat trigeminal neuralgia radiosurgery. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):38-43.

Jensen AW, Brown PD, Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL, Gorman DA, Schomberg PJ.
Gamma knife radiosurgery of radiation-induced intracranial tumors: Local control, outcomes, and complications. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):32-7.

Morris DE, Emami B, Mauch PM, Konski AA, Tao ML, Ng AK, Klein EA, Mohideen N, Hurwitz MD, Fraas BA, Roach M 3rd, Gore EM, Tepper JE.
Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An ASTRO outcomes initiative. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):3-19.

Kaal EC, Niel CG, Vecht CJ.
Therapeutic management of brain metastasis. Lancet Neurol. 2005 May;4(5):289-98.

Cernica G, Boer SF, Diaz A, Fenstermaker RA, Podgorsak MB.
Dosimetric accuracy of a staged radiosurgery treatment. Phys Med Biol. 2005 May 7;50(9):1991-2002. Epub 2005 Apr 13.

April

Hussain A, Dawson N, Amin P, Engstrom C, Dorsey B, Siegel E, Guo C.
Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer. J Clin Oncol. 2005 Apr 20;23(12):2789-96.

Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin WP, Wei JT.
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005 Apr 20;23(12):2772-80.

Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Bezjak A, Wells WA, Burns BF, Winter JN, Horning SJ, Dar AR, Djurfeldt MS, Ding K, Shepherd LE.
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin's Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol. 2005 Apr 18;

Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M.
Phase III Study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction Chemotherapy Followed by Either Standard Thoracic Radiotherapy or Hyperfractionated Accelerated Radiotherapy for Patients With Unresectable Stage IIIA and B Non-Small-Cell Lung Cancer. J Clin Oncol. 2005 Apr 18;

Lans TE, Grunhagen DJ, de Wilt JH, van Geel AN, Eggermont AM.
Isolated Limb Perfusions With Tumor Necrosis Factor and Melphalan for Locally Recurrent Soft Tissue Sarcoma in Previously Irradiated Limbs. Ann Surg Oncol. 2005 Mar 31;

Wagner M, Garzotto M, Lemmon D, Eilers KM, Beer TM.
Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer. Urology. 2005 Apr;65(4):799.

Ruffion A, Manel A, Massoud W, Decaussin M, Berger N, Paparel P, Morel-Journel N, Lopez JG, Champetier D, Devonec M, Perrin P.
Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology. 2005 Apr;65(4):703-7.

Hong SK, Kwak C, Jeon HG, Lee E, Lee SE.
Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy? Urology. 2005 Apr;65(4):697-702.

Doridot V, Meunier M, El Khoury C, Nos C, Vincent-Salomon A, Sigal-Zafrani B, Clough KB; Institut Curie Breast Cancer Group.
Stereotactic radioguided surgery by siteSelect for subclinical mammographic lesions. Ann Surg Oncol. 2005 Feb;12(2):181-8.

Schmidt CE, Bestmann B, Kuchler T, Longo WE, Kremer B.
Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol. 2005 Feb;12(2):117-23.

Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, Crepaldi G, Pasetto L, Nitti D, Lise M.
Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol. 2005 Feb;12(2):111-6.

Dvorak P, Georg D, Bogner J, Kroupa B, Dieckmann K, Potter R.
Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1572-81.

Takayama K, Nagata Y, Negoro Y, Mizowaki T, Sakamoto T, Sakamoto M, Aoki T, Yano S, Koga S, Hiraoka M.
Treatment planning of stereotactic radiotherapy for solitary lung tumor. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1565-71.

Park HC, Seong J, An JH, Kim J, Kim UJ, Lee BW.
Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1523-34.

Szumacher E, Llewellyn-Thomas H, Franssen E, Chow E, DeBoer G, Danjoux C, Hayter C, Barnes E, Andersson L.
Treatment of bone metastases with palliative radiotherapy: patients' treatment preferences. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1473-81.

Kamath R, Ryken TC, Meeks SL, Pennington EC, Ritchie J, Buatti JM.
Initial clinical experience with frameless radiosurgery for patients with intracranial metastases. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1467-72.

Lindvall P, Bergstrom P, Lofroth PO, Henriksson R, Bergenheim AT.
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1460-6.

Ringash J, Warde P, Lockwood G, O'Sullivan B, Waldron J, Cummings B.
Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1403-7.

Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR.
Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1393-402.

Paulino AC, Koshy M, Howell R, Schuster D, Davis LW.
Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1385-92.

Chapet O, Romestaing P, Mornex F, Souquet JC, Favrel V, Ardiet JM, d'Hombres A, Gerard JP.
Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors? Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1371-7.

Fay M, Tan A, Fisher R, Mac Manus M, Wirth A, Ball D.
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1355-63.

Freedman GM, Anderson PR, Hanlon AL, Eisenberg DF, Nicolaou N.
Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1328-36.

Pierce LJ, Griffith KA, Hayman JA, Douglas KR, Lichter AS.
Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1317-27.

Demanes DJ, Rodriguez RR, Schour L, Brandt D, Altieri G.
High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1306-16.

Buyyounouski MK, Hanlon AL, Horwitz EM, Uzzo RG, Pollack A.
Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1291-8.

Fowler BZ, Crocker IR, Johnstone PA.
Perineural spread of cutaneous malignancy to the brain. Cancer. 2005 Apr 6;103(10):2143-2153

Richards JC, Roden D, Harper CS.
Management of sight-threatening optic nerve sheath meningioma with fractionated stereotactic radiotherapy. Clin Experiment Ophthalmol. 2005 Apr;33(2):137-41.

Schomas DA, Roeske JC, MacDonald RL, Sweeney PJ, Mehta N, Mundt AJ.
Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol. 2005 Apr;28(2):180-7. PMID: 15803014 [PubMed - in process]

Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD.
Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol. 2005 Apr;28(2):173-9.

Hodge CW, Morris CG, Werning JW, Mendenhall WM.
Role of radiotherapy for pleomorphic adenoma. Am J Clin Oncol. 2005 Apr;28(2):148-51.

Lefranc F, Brotchi J, Kiss R.
Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol. 2005 Apr 1;23(10):2411-22. Review.

Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P.
Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol. 2005 Apr 1;23(10):2372-7.

Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willet CG, John MJ, Minsky BD, Owen JB.
Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol. 2005 Apr 1;23(10):2325-31.

Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H.
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005 Apr 1;23(10):2310-7.

Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG.
Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005 Apr 1;23(10):2300-9.

Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr.
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005 Apr 1;23(10):2272-9.

Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E.
Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol. 2005 Apr 1;23(10):2256-63.

Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R.
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol. 2005 Apr 1;23(10):2145-54.

March

Tawk RG, Duffy-Fronckowiak M, Scott BE, Alberico RA, Diaz AZ, Podgorsak MB, Plunkett RJ, Fenstermaker RA.
Stereotactic gamma knife surgery for trigeminal neuralgia: detailed analysis of treatment response. J Neurosurg. 2005 Mar;102(3):442-9.

Sheehan J, Pan HC, Stroila M, Steiner L.
Gamma knife surgery for trigeminal neuralgia: outcomes and prognostic factors. J Neurosurg. 2005 Mar;102(3):434-41.

Krishnan S, Foote RL, Brown PD, Pollock BE, Link MJ, Garces YI.
Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery. 2005 Apr;56(4):777-84; discussion 777-84.

Iwai Y, Yamanaka K, Yoshioka K.
Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery. 2005 Apr;56(4):699-705; discussion 699-705.

Muacevic A, Siebels M, Tonn JC, Wowra B.
Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? World J Urol. 2005 Mar 25;

Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, Morel P, Ferme C, Bosly A, Lederlin P, Laurent G, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA).
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005 Mar 24;352(12):1197-205.

Duncan GG, Epstein JB, Tu D, Sayed SE, Bezjak A, Ottaway J, Pater J.
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck. 2005 May;27(5):421-8.

Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, Goldberg M.
Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival. J Clin Oncol. 2005 Mar 21;

Wille S, Varga Z, von Knobloch R, Hofmann R.
Intussusception of bladder neck improves early continence after radical prostatectomy: results of a prospective trial. Urology. 2005 Mar;65(3):524-7.

Jani AB, Gratzle J, Muresan E, Farrey K, Martel MK.
Analysis of acute toxicity with use of transabdominal ultrasonography for prostate positioning during intensity-modulated radiotherapy. Urology. 2005 Mar;65(3):504-8.

El-Sherif A, Luketich JD, Landreneau RJ, Fernando HC.
New therapeutic approaches for early stage non-small cell lung cancer. Surg Oncol. 2005 Jul;14(1):27-32. Epub 2005 Jan 17.

Witham TF, Okada H, Fellows W, Hamilton RL, Flickinger JC, Chambers WH, Pollack IF, Watkins SC, Kondziolka D.
The Characterization of Tumor Apoptosis after Experimental Radiosurgery. Stereotact Funct Neurosurg. 2005 Mar 15;83(1):17-24

Loblaw DA, Perry J, Chambers A, Laperriere NJ.
Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol. 2005 Mar 20;23(9):2028-37. Review.

Dotan ZA, Bianco FJ Jr, Rabbani F, Eastham JA, Fearn P, Scher HI, Kelly KW, Chen HN, Schoder H, Hricak H, Scardino PT, Kattan MW.
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol. 2005 Mar 20;23(9):1962-8.

Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, Harris JR, Recht A.
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005 Mar 20;23(9):1934-40.

Engelsman M, Sharp GC, Bortfeld T, Onimaru R, Shirato H.
How much margin reduction is possible through gating or breath hold? Phys Med Biol. 2005 Feb 7;50(3):477-90.

Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ.
Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. Neurosurg Focus. 2005 Mar 15;18(3):e8.

Leong T, Willis D, Joon DL, Condron S, Hui A, Ngan SY.
3D conformal radiotherapy for gastric cancer--results of a comparative planning study. Radiother Oncol. 2005 Mar;74(3):301-6.

Martin J, Fitzpatrick K, Horan G, McCloy R, Buckney S, O'Neill L, Faul C.
Treatment with a belly-board device significantly reduces the volume of small bowel irradiated and results in low acute toxicity in adjuvant radiotherapy for gynecologic cancer: results of a prospective study. Radiother Oncol. 2005 Mar;74(3):267-74.

Aass N, Fossa SD.
Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression. Radiother Oncol. 2005 Mar;74(3):259-65. Epub 2004 Dec 21.

Saarilahti K, Kouri M, Collan J, Hamalainen T, Atula T, Joensuu H, Tenhunen M.
Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol. 2005 Mar;74(3):251-8.

Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, Dumas I, Hellebust TP, Kirisits C, Lang S, Muschitz S, Nevinson J, Nulens A, Petrow P, Wachter-Gerstner N; Gynaecological (GYN) GEC-ESTRO Working Group.
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005 Mar;74(3):235-45.

Gerard JP.
The Estro Regaud Lecture. Radiotherapy in the conservative treatment of rectal cancer. Evidence-based medicine and opinion. Radiother Oncol. 2005 Mar;74(3):227-33.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96.

Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J.
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005 Mar 10;352(10):978-86.

Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS.
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol. 2005 Apr 1;23(10):2208-14. Epub 2005 Mar 7.

Park W, Lim do H, Paik SW, Koh KC, Choi MS, Park CK, Yoo BC, Lee JE, Kang MK, Park YJ, Nam HR, Ahn YC, Huh SJ.
Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1143-50.

Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV, Filho WJ, Lopes A.
Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1136-42.

Allal AS, Gervaz P, Gertsch P, Bernier J, Roth AD, Morel P, Bieri S.
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1129-35.

Prosnitz RG, Yao B, Farrell CL, Clough R, Brizel DM.
Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1087-95.

Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W Jr, Mundt AJ.
Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1078-86.

Suh WW, Hillner BE, Pierce LJ, Hayman JA.
Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1054-61.

al-Abany M, Helgason AR, Cronqvist AK, Lind B, Mavroidis P, Wersall P, Lind H, Qvanta E, Steineck G.
Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1035-44.

Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC.
Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34.

Heemsbergen WD, Hoogeman MS, Hart GA, Lebesque JV, Koper PC.
Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1011-8.

Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D.
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):993-1002.

Moreton P, Kennedy B, Lucas G, Leach M, Rassam SM, Haynes A, Tighe J, Oscier D, Fegan C, Rawstron A, Hillmen P.
Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. J Clin Oncol. 2005 May 1;23(13):2971-9. Epub 2005 Feb 28.

Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A.
Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer. J Clin Oncol. 2005 Feb 28;

Mamon HJ, Yeap BY, Janne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R.
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005 Mar 1;23(7):1530-7.

Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS.
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol. 2005 Mar 1;23(7):1507-13.

Smith BD, Smith GL, Haffty BG.
Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol. 2005 Mar 1;23(7):1409-19.

Colleoni M, Zahrieh D, Gelber RD, Holmberg SB, Mattsson JE, Rudenstam CM, Lindtner J, Erzen D, Snyder R, Collins J, Fey MF, Thurlimann B, Crivellari D, Murray E, Mendiola C, Pagani O, Castiglione-Gertsch M, Coates AS, Price K, Goldhirsch A.
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol. 2005 Mar 1;23(7):1390-400.

Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, Luini A, Intra M, Veronesi P, Galimberti V, Torrisi R, Cardillo A, Goldhirsch A, Viale G.
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005 Mar 1;23(7):1379-89.

February

D'Addario G, Pintilie M, Leighl NB, Feld R, Cerny T, Shepherd FA.
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature. J Clin Oncol. 2005 May 1;23(13):2926-36. Epub 2005 Feb 22.

Soares HP, Kumar A, Daniels S, Swann S, Cantor A, Hozo I, Clark M, Serdarevic F, Gwede C, Trotti A, Djulbegovic B.
Evaluation of new treatments in radiation oncology: are they better than standard treatments? JAMA. 2005 Feb 23;293(8):970-8.

Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ.
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck. 2005 May;27(5):406-14.

Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP.
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol. 2005 Feb 20;23(6):1200-8.

Sathya JR, Davis IR, Julian JA, Guo Q, Daya D, Dayes IS, Lukka HR, Levine M.
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol. 2005 Feb 20;23(6):1192-9.

Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD.
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol. 2005 Feb 20;23(6):1125-35.

Astreinidou E, Bel A, Raaijmakers CP, Terhaard CH, Lagendijk JJ.
Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):938-44.

Yu J, Li G, Li J, Wang Y.
The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):874-8.

Chow E, Davis L, Panzarella T, Hayter C, Szumacher E, Loblaw A, Wong R, Danjoux C.
Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):870-3.

Monroe AT, Bhandare N, Morris CG, Mendenhall WM.
Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):856-64.

Nieder C, Grosu AL, Andratschke NH, Molls M.
Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):851-5. Review.

Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J.
Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):809-16.

Paek SH, Downes MB, Bednarz G, Keane WM, Werner-Wasik M, Curran WJ Jr, Andrews DW.
Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):795-808. Review.

Hansen O, Larsen S, Bastholt L, Godballe C, Jorgensen KE.
Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):789-94.

Hong TS, Tome WA, Chappell RJ, Chinnaiyan P, Mehta MP, Harari PM.
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):779-88.

Sanguineti G, Richetti A, Bignardi M, Corvo' R, Gabriele P, Sormani MP, Antognoni P.
Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):762-71.

Niazi TM, Souhami L, Sultanem K, Duclos M, Shenouda G, Freeman C.
Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):741-4.

Choo R, Thomas G, Woo T, Lee D, Kong B, Iscoe N, Danjoux C, Klotz L, Morton G, Chander S.
Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):736-40.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A.
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):695-701.

Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.
Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77.

Nicolato A, Giorgetti P, Foroni R, Grigolato D, Pasquin IP, Zuffante M, Soda C, Tomassini A, Gerosa M.
Gamma knife radiosurgery in skull base meningiomas: a possible relationship between somatostatin receptor decrease and early neurological improvement without tumour shrinkage at short-term imaging follow-up. Acta Neurochir (Wien). 2005 Apr;147(4):367-75.

Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER; Glioma Outcomes Project Investigators.
Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005 Feb 2;293(5):557-64.

Shioyama Y, Nakamura K, Sasaki T, Ooga S, Urashima Y, Kimura M, Uehara S, Terashima H, Honda H.
Clinical results of radiation therapy for stage I esophageal cancer: a single institutional experience. Am J Clin Oncol. 2005 Feb;28(1):75-80.

Katz TS, Amdur RJ, Yachnis AT, Mendenhall WM, Morris CG.
Pushing the limits of radiotherapy for atypical and malignant meningioma. Am J Clin Oncol. 2005 Feb;28(1):70-4.

Taylor JM, Yu M, Sandler HM.
Individualized predictions of disease progression following radiation therapy for prostate cancer. J Clin Oncol. 2005 Feb 1;23(4):816-25.

Lawton CA, Winter K, Grignon D, Pilepich MV.
Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31. J Clin Oncol. 2005 Feb 1;23(4):800-7.

Brouha XD, Tromp DM, de Leeuw JR, Hordijk GJ, Winnubst JA.
Laryngeal cancer patients: analysis of patient delay at different tumor stages. Head Neck. 2005 Apr;27(4):289-95.

Wong JR, Grimm L, Uematsu M, Oren R, Cheng CW, Merrick S, Schiff P.
Image-guided radiotherapy for prostate cancer by CT-linear accelerator combination: prostate movements and dosimetric considerations. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):561-9.

Stalpers LJ, da Costa HC, Merbis MA, Fortuin AA, Muller MJ, van Dam FS.
Hypnotherapy in radiotherapy patients: a randomized trial. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):499-506.

DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD.
Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):492-8.

Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, Lu TX, Min HQ.
Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol. 2005 Feb 20;23(6):1118-24. Epub 2005 Jan 18.

Tomura N, Izumi J, Anbai A, Takahashi S, Sakuma I, Omachi K, Kidani H, Sasaki K, Watarai J, Suzuki A, Mizoi K.
Thallium-201 SPECT in the evaluation of early effects on brain tumors treated with stereotactic irradiation. Clin Nucl Med. 2005 Feb;30(2):83-6.

Josting A, Nogova L, Franklin J, Glossmann JP, Eich HT, Sieber M, Schober T, Boettcher HD, Schulz U, Muller RP, Diehl V, Engert A.
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. J Clin Oncol. 2005 Mar 1;23(7):1522-9. Epub 2005 Jan 4.

Taussky D, Dulguerov P, Allal AS.
Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck. 2005 Mar;27(3):182-6.

Veness MJ, Morgan GJ, Gebski V.
Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck. 2005 Mar;27(3):208-16.

Leung WM, Tsang NM, Chang FT, Lo CJ.
Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy. Head Neck. 2005 Mar;27(3):187-94.

February

Fried DB, Morris DE, Poole C, Rosenman JG, Halle JS, Detterbeck FC, Hensing TA, Socinski MA.
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol. 2004 Dec 1;22(23):4837-45. Review. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

Ahn PH, Vu HT, Lannin D, Obedian E, DiGiovanna MP, Burtness B, Haffty BG.
Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates. J Clin Oncol. 2005 Jan 1;23(1):17-23. Epub 2004 Nov 15.

Harris EE, Christensen VJ, Hwang WT, Fox K, Solin LJ.
Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol. 2005 Jan 1;23(1):11-6. Epub 2004 Nov 15.

Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thoni A, Ozsahin M, Bernier J, Topfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C.
Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol. 2004 Dec 1;22(23):4665-73. Epub 2004 Nov 8. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

Sewnaik A, Meeuwis CA, van der Kwast TH, Kerrebijn JD.
Partial laryngectomy for recurrent glottic carcinoma after radiotherapy. Head Neck. 2005 Feb;27(2):101-7.

Diaz EM Jr, Johnigan RH 3rd, Pero C, El-Naggar AK, Roberts DB, Barker JL, Demonte F.
Olfactory neuroblastoma: The 22-year experience at one comprehensive cancer center. Head Neck. 2005 Feb;27(2):138-49.

Delanian S, Depondt J, Lefaix JL.
Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: A phase II trial. Head Neck. 2005 Feb;27(2):114-23.

Sewnaik A, Meeuwis CA, van der Kwast TH, Kerrebijn JD.
Partial laryngectomy for recurrent glottic carcinoma after radiotherapy. Head Neck. 2005 Feb;27(2):101-7.

Devin JK, Allen GS, Cmelak AJ, Duggan DM, Blevins LS.
The Efficacy of Linear Accelerator Radiosurgery in the Management of Patients with Cushing's Disease. Stereotact Funct Neurosurg. 2005 Jan 20;82(5-6):254-262

Maruyama K, Kawahara N, Shin M, Tago M, Kishimoto J, Kurita H, Kawamoto S, Morita A, Kirino T.
The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005 Jan 13;352(2):146-53.

Pollock BE, Foote RL, Link MJ, Stafford SL, Brown PD, Schomberg PJ.
Repeat radiosurgery for idiopathic trigeminal neuralgia. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):192-5.

Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, Mathieu MC, Oberlin O, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Chavaudra J, de Vathaire F.
Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol. 2005 Jan 1;23(1):197-204.

Pierce LJ, Hutchins LF, Green SR, Lew DL, Gralow JR, Livingston RB, Osborne CK, Albain KS.
Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. J Clin Oncol. 2005 Jan 1;23(1):24-9. Epub 2004 Nov 15.

Ahn PH, Vu HT, Lannin D, Obedian E, DiGiovanna MP, Burtness B, Haffty BG.
Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates. J Clin Oncol. 2005 Jan 1;23(1):17-23. Epub 2004 Nov 15.

Harris EE, Christensen VJ, Hwang WT, Fox K, Solin LJ.
Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol. 2005 Jan 1;23(1):11-6. Epub 2004 Nov 15.

Sartor CI, Peterson BL, Woolf S, Fitzgerald TJ, Laurie F, Turrisi AJ, Bogart J, Henderson IC, Norton L.
Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol. 2005 Jan 1;23(1):30-40. Epub 2004 Nov 15.

Sheehan J, Kondziolka D, Flickinger J, Lunsford LD.
Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg. 2005 Jan;102 Suppl:247-54.

Sheehan J, Kondziolka D, Flickinger J, Lunsford LD.
Gamma knife surgery for glomus jugulare tumors: an intermediate report on efficacy and safety. J Neurosurg. 2005 Jan;102 Suppl:241-6.

Wang EM, Pan L, Wang BJ, Zhang N, Zhou LF, Dong YF, Dai JZ, Cai PW, Chen H.
The long-term results of gamma knife radiosurgery for hemangioblastomas of the brain. J Neurosurg. 2005 Jan;102 Suppl:225-9.

Liscak R, Vladyka V, Simonova G, Vymazal J, Novotny J Jr.
Gamma knife surgery of brain cavernous hemangiomas. J Neurosurg. 2005 Jan;102 Suppl:207-13.

van Eck AT, Horstmann GA.
Increased preservation of functional hearing after gamma knife surgery for vestibular schwannoma. J Neurosurg. 2005 Jan;102 Suppl:204-6.

Lunsford LD, Niranjan A, Flickinger JC, Maitz A, Kondziolka D.
Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg. 2005 Jan;102 Suppl:195-9.

Szeifert GT, Salmon I, Rorive S, Massager N, Devriendt D, Simon S, Brotchi J, Levivier M.
Does gamma knife surgery stimulate cellular immune response to metastatic brain tumors? A histopathological and immunohistochemical study. J Neurosurg. 2005 Jan;102 Suppl:180-4.

Gerosa M, Nicolato A, Foroni R, Tomazzoli L, Bricolo A.
Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery. J Neurosurg. 2005 Jan;102 Suppl:75-80.

Picozzi P, Losa M, Mortini P, Valle MA, Franzin A, Attuati L, Ferrari da Passano C, Giovanelli M.
Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg. 2005 Jan;102 Suppl:71-4.